Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramyometrial oxytocin versus placebo during abdominal myomectomy
PACTR202606720982011Phase 2Recruiting
- Sponsor
- Omotehinse Demisi Oluwole
- Start
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of oxytocin and Normal Saline-Benha University in Fibromyoma (LM) (2 arms), sponsored by Omotehinse Demisi Oluwole. Primary endpoint: Estimated intraoperative blood loss. Started Feb 2026; status: recruiting.
02
Drugs
oxytocinNormal Saline-Benha University
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202606720982011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606720982011.